CLINICAL_TRIALS ClinicalTrials.gov record update

The Role of Lovaza® on Microvascular Function and Lipoprotein Profile in Type 2 Diabetes

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00931879
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:34.585596+00:00
Published At: 2017-05-09T00:00:00+00:00
Record Updated At: 2017-05-09
Results Posted At: 2017-05-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hypertriglyceridemia", "Diabetic Neuropathy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-05-09"
protocolSection.identificationModule.nctId: "NCT00931879"
protocolSection.identificationModule.officialTitle: "The Role of Lovaza\u00ae on Microvascular Function and Lipoprotein Profile in Type 2 Diabetes"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-05-09"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.